Ontology highlight
ABSTRACT: Background
Type 2 diabetes patients often initiate treatment with a sulfonylurea and subsequently intensify their therapy with insulin. However, information on optimal treatment regimens for these patients is limited.Objective
To compare risk of cardiovascular disease (CVD) and hypoglycemia between sulfonylurea initiators who switch to or add insulin.Design
This was a retrospective cohort assembled using national Veterans Health Administration (VHA), Medicare, and National Death Index databases.Participants
Veterans who initiated diabetes treatment with a sulfonylurea between 2001 and 2008 and intensified their regimen with insulin were followed through 2011.Main measures
The association between insulin versus sulfonylurea + insulin and time to CVD o
SUBMITTER: Min JY
PROVIDER: S-EPMC4870423 | biostudies-literature | 2016 Jun
REPOSITORIES: biostudies-literature